Johanna Mercier insider trades

Open-market stock purchases and sales by Johanna Mercier, Chief Comm & Corp Aff Officer at Gilead Sciences, Inc, from SEC Form 4 filings since Jul 24, 2019.

Recent trades

DateStockTradeValue
Sep 15, 2026GILD Gilead Sciences, IncSold$230K
Sep 15, 2026GILD Gilead Sciences, IncSold$116K
Sep 15, 2026GILD Gilead Sciences, IncSold$87.2K
Sep 10, 2026GILD Gilead Sciences, IncSold (not open market)$195K
Sep 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Aug 17, 2026GILD Gilead Sciences, IncSold$2.3M
Aug 17, 2026GILD Gilead Sciences, IncSold$1.6M
Aug 17, 2026GILD Gilead Sciences, IncBought (not open market)—
Aug 17, 2026GILD Gilead Sciences, IncBought (not open market)—
Jul 15, 2026GILD Gilead Sciences, IncSold$390K
Jun 15, 2026GILD Gilead Sciences, IncSold$183K
Jun 15, 2026GILD Gilead Sciences, IncSold$133K
Jun 15, 2026GILD Gilead Sciences, IncSold$56.4K
Jun 10, 2026GILD Gilead Sciences, IncSold (not open market)$163K
Jun 10, 2026GILD Gilead Sciences, IncBought (not open market)—
May 27, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 21, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 15, 2026GILD Gilead Sciences, IncSold$1M
May 15, 2026GILD Gilead Sciences, IncSold$1.1M
May 15, 2026GILD Gilead Sciences, IncSold$1.5M
May 15, 2026GILD Gilead Sciences, IncSold$92.9K
May 15, 2026GILD Gilead Sciences, IncBought (not open market)—
Apr 15, 2026GILD Gilead Sciences, IncSold$423K
Mar 16, 2026GILD Gilead Sciences, IncSold$433K
Mar 10, 2026GILD Gilead Sciences, IncBought (not open market)—

Companies traded

  • GILD Gilead Sciences, Inc: 39 sales, last Sep 15, 2026
  • NBIX Neurocrine Biosciences Inc: other filings, last May 27, 2026

Get free alerts when Johanna Mercier files a new trade →